Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy
Carmel McVicar(Queen's University Belfast), Alan W. Stitt(Queen's University Belfast), Michael Brines(Northwell Health), R. Hamilton(Queen's University Belfast), Tom A. Gardiner(National Physical Laboratory), Liza Colhoun(Queen's University Belfast), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 114
Related Papers
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
|JCI Insight|2017|1k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k